chr11-110233356-C-T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_002906.4(RDX):c.1468G>A(p.Asp490Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000159 in 1,614,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_002906.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RDX | NM_002906.4 | c.1468G>A | p.Asp490Asn | missense_variant | 13/14 | ENST00000645495.2 | NP_002897.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RDX | ENST00000645495.2 | c.1468G>A | p.Asp490Asn | missense_variant | 13/14 | NM_002906.4 | ENSP00000496503.2 |
Frequencies
GnomAD3 genomes AF: 0.000821 AC: 125AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000199 AC: 50AN: 251474Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135912
GnomAD4 exome AF: 0.0000896 AC: 131AN: 1461868Hom.: 0 Cov.: 33 AF XY: 0.0000825 AC XY: 60AN XY: 727234
GnomAD4 genome AF: 0.000821 AC: 125AN: 152282Hom.: 0 Cov.: 32 AF XY: 0.000819 AC XY: 61AN XY: 74456
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 10, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 16, 2019 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 31, 2021 | Variant classified as Uncertain Significance - Favor Benign. The p.Asp490Asn variant in RDX has been reported in the heterozygous state in 2 individuals with hearing loss (LMM data), but has also been identified in 0.24% (62/24972) of African chromosomes by gnomAD (http://gnomad.broadinstitute.org). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, while the clinical significance of this variant is uncertain, its frequency suggests it is more likely to be benign. ACMG/AMP Criteria applied: BS1_Supporting. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at